Tel Aviv University’s TTO has set up a business called Nemis Technologies in partnership with BioSynth to develop pathological bacteria detection technologies powered by chemiluminescence.
Ramot, the tech transfer and business engagement arm of Tel Aviv University, joined forces with biochemicals supplier BioSynth today to launch Israel-based bacteria detection technology developer Nemis Technologies.
Nemis will leverage a pathogenic bacteria detection technology called AquaSpark co-developed by Ramot and Biosynth to build diagnostic kits that could be used to prevent contamination in food production, water treatment and clinical settings.
The technology is a response to fears over the growing number of food-borne illnesses and antibiotic…
